Starting slow can make a big difference
In a subgroup of patients that became hypoglycemic during the baseline mixed meal challenge, across all doses of mizagliflozin (combined), compared with baseline, the glucose nadir was raised by 19.3 mg/dL (38%) (p=0.03), the glucose peak was lowered by -36.3 mg/dL (21%) (p=0.03), and the insulin peak was lowered by -324.5 IU/mL (53%) (p=0.016)
And the most successful people I know who have gone off GLP-1s, who have lost an enormous amount of weight and kept it off without it
This doctor developed, 3-part system works together to support GLP-1 users and their side effects
GLP-1s Show Promise, but New Uses Arent Here Yet Editorial Sources and Fact-Checking GLP-1 Agonists
TL;DR Zepbound (tirzepatide) and Trulicity (dulaglutide) are both manufactured by Eli Lilly but serve different primary purposes